EUVIMEDEUVIMED entdecken
MetaanalyseOpen Access · CC BY 4.0

The Role of VEGFA in T2DM-Nephropathy: A Genetic Association Study and Meta-Analysis

Maria Tziastoudi iD, Christos Cholevas iD, Constantinos Zorz, Efthimios Dardiotis, Evangelia E Tsironi iD, Maria Divani, Theodoros Eleftheriadis iD, Ioannis Stefanidis iD

Genes · 2025

DOI: 10.3390/genes16111386 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Genes, 2025. Verfasst von Maria Tziastoudi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Faculty of Medicine, University of Thessaly, 41110 Larissa, Greece. Hauptthemen laut MEDLINE: Vascular Endothelial Growth Factor A, Diabetic Nephropathies, Polymorphism, Single Nucleotide, Diabetes Mellitus, Type 2. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Diabetic nephropathy (DN) is a leading cause of end-stage renal disease, arising from complex interactions between metabolic, hemodynamic, and genetic factors. Among candidate genes, vascular endothelial growth factor A (VEGFA) has been extensively investigated due to its role in endothelial homeostasis and microvascular complications of diabetes. The present study aimed to examine the association of VEGFA polymorphisms with DN in a Greek population and to perform a comprehensive meta-analysis of available evidence.

Methods

A case–control study was conducted, including 197 patients with type 2 diabetes mellitus (T2DM) and DN, 155 diabetic patients without nephropathy, and 246 healthy controls. Ten tagging single-nucleotide polymorphisms (SNPs) across VEGFA were genotyped. Statistical analyses employed the generalized odds ratio (ORG). To contextualize these findings, a meta-analysis of 13 eligible studies was performed, encompassing 7520 cases, 6951 diabetic controls, and 1718 healthy controls.

Results

Of the tested variants in the present case–control study, only rs833070 was significantly associated with DN across all comparisons. Nine VEGFA variants were evaluated in meta-analysis, with rs2146323 showing a protective effect (allelic OR = 0.85; 95% CI: 0.76–0.95), while other variants yielded non-significant associations.

Conclusions

Overall, the data suggest that VEGFA polymorphisms, particularly rs833070 and rs2146323, contribute to genetic susceptibility to DN, although population-specific differences and heterogeneity across studies remain substantial. Future research in large, ethnically diverse cohorts with functional analyses is warranted to clarify causal mechanisms and enable the integration of VEGFA genetic variation into risk stratification and personalized therapeutic strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Vascular Endothelial Growth Factor ADiabetic NephropathiesPolymorphism, Single NucleotideDiabetes Mellitus, Type 2HumansMaleCase-Control StudiesGenetic Predisposition to DiseaseFemaleMiddle AgedGenetic Association StudiesAged

Stichwörter der Autor:innen

diabetes mellitusdiabetic nephropathygenetic association studymeta-analysisvascular endothelial growth factor (VEGFA)

Substanzen

Vascular Endothelial Growth Factor AVEGFA protein, human

Autor:innen und Institutionen

  • Department of Nephrology, Faculty of Medicine, University of Thessaly, 41110 Larissa, Greece.
  • Laboratory of Pharmaceutical Technology, Division of Pharmaceutical Technology, School of Pharmacy, Faculty of Health Sciences, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece.
  • Department of Neurology, University Hospital of Larissa, Faculty of Medicine, School of Health Sciences, University of Thessaly, 41110 Larissa, Greece.
  • Department of Ophthalmology, Faculty of Medicine, School of Health Sciences, University of Thessaly, 41110 Larissa, Greece.

ORCID-Profile: Maria Tziastoudi, Christos Cholevas, Evangelia E Tsironi, Theodoros Eleftheriadis, Ioannis Stefanidis

Zitieren

APA

Tziastoudi, M., Cholevas, C., Zorz, C., Dardiotis, E., Tsironi, E. E., Divani, M., Eleftheriadis, T., & Stefanidis, I. (2025). The Role of VEGFA in T2DM-Nephropathy: A Genetic Association Study and Meta-Analysis. Genes. https://doi.org/10.3390/genes16111386

Vancouver

Tziastoudi M, Cholevas C, Zorz C, Dardiotis E, Tsironi EE, Divani M, et al. The Role of VEGFA in T2DM-Nephropathy: A Genetic Association Study and Meta-Analysis. Genes. 2025. doi:10.3390/genes16111386

BibTeX
@article{Tziastoudi2025,
  author = {Tziastoudi, Maria and Cholevas, Christos and Zorz, Constantinos and Dardiotis, Efthimios and Tsironi, Evangelia E and Divani, Maria and Eleftheriadis, Theodoros and Stefanidis, Ioannis},
  title = {The Role of VEGFA in T2DM-Nephropathy: A Genetic Association Study and Meta-Analysis},
  journal = {Genes},
  year = {2025},
  doi = {10.3390/genes16111386}
}
Kostenlos starten →